LIXOFT

Lixoft was founded in 2011, after a seven years research program in statistics and modeling for drug development and clinical trials, led by Inria in collaboration with Inserm and sponsored by Johnson & Johnson, Sanofi, Novartis, Roche, Astrazeneca and Exprimo... Lixoft develops modeling and simulation software for advanced model-based drug development. Its products offer powerful and easy solutions for population analysis in pre-clinical, clinical trials and in treatment individualization.

VAT numbers: FR60532514205

Primary location: Antony France